Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001087046 | SCV000286413 | likely benign | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2024-12-27 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000308363 | SCV000333029 | uncertain significance | not provided | 2015-07-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000308363 | SCV001795232 | likely benign | not provided | 2020-11-23 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002408961 | SCV002675582 | uncertain significance | Cardiovascular phenotype | 2019-06-24 | criteria provided, single submitter | clinical testing | The p.N26283K variant (also known as c.78849C>A), located in coding exon 185 of the TTN gene, results from a C to A substitution at nucleotide position 78849. The asparagine at codon 26283 is replaced by lysine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
CHEO Genetics Diagnostic Laboratory, |
RCV003150136 | SCV003838500 | benign | Cardiomyopathy | 2021-08-27 | criteria provided, single submitter | clinical testing |